[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca] Read More > September 17, 2015
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning Read More > September 15, 2015
LSD Flashbacks – The Appearance of New Visual Imagery Not Experienced During Initial Intoxication: Two Case Reports. Read More > September 14, 2015
Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders Read More > September 8, 2015
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects Read More > September 1, 2015
Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices Read More > September 1, 2015
